Vimarsana
Biggest News Aggregation in the World

Bryan Traynor News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bryan Traynor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bryan Traynor Today - Breaking & Trending Today

Emory pioneers ALS genetic data repository with NIH and UMass Chan Medical School - Vimarsana News

Emory pioneers ALS genetic data repository with NIH and UMass Chan Medical School

In a notable advancement in the battle against ALS and frontotemporal dementia, Emory University, in collaboration with UMass Chan Medical School and the National Institutes of Health, has secured over $3 million in support from The ALS Association to establish a pioneering cloud-based central repository of genetic data, named ALS Compute.

Source: emory.edu
FDA seems poised to approve a new drug for ALS, but does it work? - Health - NPR News - Vimarsana News

FDA seems poised to approve a new drug for ALS, but does it work? - Health - NPR News

FDA seems poised to approve a new drug for ALS, but does it work?

Source: wmfe.org
Despite concens, FDA panel reverses course on ALS drug and recommends approval : Shots - Vimarsana News

Despite concens, FDA panel reverses course on ALS drug and recommends approval : Shots

In March, experts who advise the FDA questioned the efficacy of an experimental new drug for ALS. In September, they voted to approve it anyway.

Source: npr.org
FDA seems poised to approve a new drug for ALS, but does it work? - Vimarsana News

FDA seems poised to approve a new drug for ALS, but does it work?

In March, experts who advise the FDA questioned the efficacy of an experimental new drug for ALS. In September, they voted to approve it anyway.

Source: wprl.org
FDA seems poised to approve a new drug for ALS, but does it work? - Vimarsana News

FDA seems poised to approve a new drug for ALS, but does it work?

In March, experts who advise the FDA questioned the efficacy of an experimental new drug for ALS. In September, they voted to approve it anyway.

Source: kpbs.org